Your browser doesn't support javascript.
loading
A homozygous splice variant in ATP5PO, disrupts mitochondrial complex V function and causes Leigh syndrome in two unrelated families.
Ganapathi, Mythily; Friocourt, Gaelle; Gueguen, Naig; Friederich, Marisa W; Le Gac, Gerald; Okur, Volkan; Loaëc, Nadège; Ludwig, Thomas; Ka, Chandran; Tanji, Kurenai; Marcorelles, Pascale; Theodorou, Evangelos; Lignelli-Dipple, Angela; Voisset, Cécile; Walker, Melissa A; Briere, Lauren C; Bourhis, Amélie; Blondel, Marc; LeDuc, Charles; Hagen, Jacob; Cooper, Cathleen; Muraresku, Colleen; Ferec, Claude; Garenne, Armelle; Lelez-Soquet, Servane; Rogers, Cassandra A; Shen, Yufeng; Strode, Dana K; Bizargity, Peyman; Iglesias, Alejandro; Goldstein, Amy; High, Frances A; Network, Undiagnosed Diseases; Sweetser, David A; Ganetzky, Rebecca; Van Hove, Johan L K; Procaccio, Vincent; Le Marechal, Cedric; Chung, Wendy K.
Affiliation
  • Ganapathi M; Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.
  • Friocourt G; Univ Brest, Inserm, EFS, UMR1078, France.
  • Gueguen N; MitoLab, UMR CNRS 6015 - INSERM U1083, MitoVasc Institute, Angers University Hospital, Angers, France.
  • Friederich MW; Section of Clinical Genetics and Metabolism, Department of Pediatrics, University of Colorado, Aurora, Colorado, USA.
  • Le Gac G; Department of Pathology and Laboratory Medicine, Children's Hospital Colorado, Aurora, Colorado, USA.
  • Okur V; Univ Brest, Inserm, EFS, UMR1078, France.
  • Loaëc N; CHRU de Brest, Service de Génétique Médicale et Biologie de la Reproduction, Laboratoire de Génétique Moléculaire et Histocompatibilité, France.
  • Ludwig T; Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, USA.
  • Ka C; Univ Brest, Inserm, EFS, UMR1078, France.
  • Tanji K; Univ Brest, Inserm, EFS, UMR1078, France.
  • Marcorelles P; CHRU de Brest, Service de Génétique Médicale et Biologie de la Reproduction, Laboratoire de Génétique Moléculaire et Histocompatibilité, France.
  • Theodorou E; Univ Brest, Inserm, EFS, UMR1078, France.
  • Lignelli-Dipple A; CHRU de Brest, Service de Génétique Médicale et Biologie de la Reproduction, Laboratoire de Génétique Moléculaire et Histocompatibilité, France.
  • Voisset C; Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.
  • Walker MA; CHRU de Brest, Service d'anatomie cytologie pathologie, CHU et centre de référence des maladies neuromusculaires, Brest, France.
  • Briere LC; Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Bourhis A; Division of Medical Genetics & Metabolism, Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Blondel M; Department of Radiology, Columbia University Irving Medical Center, New York, New York, USA.
  • LeDuc C; Univ Brest, Inserm, EFS, UMR1078, France.
  • Hagen J; Division of Neurogenetics, Child Neurology, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Cooper C; Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Muraresku C; CHRU de Brest, Service d'anatomie cytologie pathologie, CHU et centre de référence des maladies neuromusculaires, Brest, France.
  • Ferec C; Univ Brest, Inserm, EFS, UMR1078, France.
  • Garenne A; Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, USA.
  • Lelez-Soquet S; Department of Biomedical Sciences, Columbia University Irving Medical Center, New York, New York, USA.
  • Rogers CA; Department of Radiology, Columbia University Irving Medical Center, New York, New York, USA.
  • Shen Y; Department of Pediatrics, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Strode DK; Mitochondrial Medicine Frontier Program, Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Bizargity P; Univ Brest, Inserm, EFS, UMR1078, France.
  • Iglesias A; CHRU de Brest, Service de Pédiatrie, France.
  • Goldstein A; CHRU de Brest, Service de Radiologie, France.
  • High FA; Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Network UD; Department of Biomedical Sciences, Columbia University Irving Medical Center, New York, New York, USA.
  • Sweetser DA; Section of Clinical Genetics and Metabolism, Department of Pediatrics, University of Colorado, Aurora, Colorado, USA.
  • Ganetzky R; Division of Medical Genetics, Cohen Children's Medical Center, New York, New York, USA.
  • Van Hove JLK; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, New York, USA.
  • Procaccio V; Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, USA.
  • Le Marechal C; Department of Pediatrics, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Chung WK; Mitochondrial Medicine Frontier Program, Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
J Inherit Metab Dis ; 45(5): 996-1012, 2022 09.
Article de En | MEDLINE | ID: mdl-35621276
ABSTRACT
Mitochondrial complex V plays an important role in oxidative phosphorylation by catalyzing the generation of ATP. Most complex V subunits are nuclear encoded and not yet associated with recognized Mendelian disorders. Using exome sequencing, we identified a rare homozygous splice variant (c.87+3A>G) in ATP5PO, the complex V subunit which encodes the oligomycin sensitivity conferring protein, in three individuals from two unrelated families, with clinical suspicion of a mitochondrial disorder. These individuals had a similar, severe infantile and often lethal multi-systemic disorder that included hypotonia, developmental delay, hypertrophic cardiomyopathy, progressive epileptic encephalopathy, progressive cerebral atrophy, and white matter abnormalities on brain MRI consistent with Leigh syndrome. cDNA studies showed a predominant shortened transcript with skipping of exon 2 and low levels of the normal full-length transcript. Fibroblasts from the affected individuals demonstrated decreased ATP5PO protein, defective assembly of complex V with markedly reduced amounts of peripheral stalk proteins, and complex V hydrolytic activity. Further, expression of human ATP5PO cDNA without exon 2 (hATP5PO-∆ex2) in yeast cells deleted for yATP5 (ATP5PO homolog) was unable to rescue growth on media which requires oxidative phosphorylation when compared to the wild type construct (hATP5PO-WT), indicating that exon 2 deletion leads to a non-functional protein. Collectively, our findings support the pathogenicity of the ATP5PO c.87+3A>G variant, which significantly reduces but does not eliminate complex V activity. These data along with the recent report of an affected individual with ATP5PO variants, add to the evidence that rare biallelic variants in ATP5PO result in defective complex V assembly, function and are associated with Leigh syndrome.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Encéphalopathies / Maladie de Leigh / Mitochondrial Proton-Translocating ATPases Type d'étude: Etiology_studies / Prognostic_studies Limites: Humans Langue: En Journal: J Inherit Metab Dis Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Encéphalopathies / Maladie de Leigh / Mitochondrial Proton-Translocating ATPases Type d'étude: Etiology_studies / Prognostic_studies Limites: Humans Langue: En Journal: J Inherit Metab Dis Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
...